EWG Elevate’s enVVeno Medical NVNO Stock Holding History

EWG Elevate’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9	Closed	-$1.61K	–	530
2022 Q4	$1.61K	Buy	+9	New	+$1.83K	﹤0.01%	607

Other funds holding NVNO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AMCA

Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return

EWG Elevate's NVNO Position: Q1 2023 in Review

EWG Elevate sold out of enVVeno Medical (NVNO) in Q1 2023, closing a stake of 9 shares — an estimated $1.61K sold.

EWG Elevate first reported a position in NVNO in Q4 2022 and held it in 1 quarter. The position peaked at $1.61K in Q4 2022. 18 funds tracked by Wall St. Rank hold NVNO as of Q1 2023.

EWG Elevate reported no remaining enVVeno Medical position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 9 enVVeno Medical shares in Q1 2023, an estimated $1.61K.
EWG Elevate first reported a position in enVVeno Medical in Q4 2022 and held it in 1 quarter.
EWG Elevate's enVVeno Medical position peaked at $1.61K in Q4 2022.
18 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.